当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析

毕得医药

(688073)

  

流通市值:14.94亿  总市值:31.91亿
流通股本:4255.19万   总股本:9088.29万

毕得医药(688073)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.26亿元,每股收益0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益204524.03万元,未分配利润25066.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产238191.95万元,负债33667.92万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入262,669,977.51,091,858,561.97805,006,735.83522,625,316.59
营业总成本225,411,993.32940,546,450.07654,533,379.99409,834,164.7
营业利润31,187,836.18126,629,167.17132,365,140.4698,007,753.05
利润总额31,310,230.44125,996,771.38131,930,720.4497,442,737.78
净利润26,074,943108,446,298.78112,647,629.6283,583,027.36
其他综合收益-339,064.78282,987.35-8,619,012.01-19,177,951.89
综合收益总额25,735,878.22108,729,286.13104,028,617.6164,405,075.47
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,239,748,244.092,261,166,147.472,202,752,640.652,195,902,104.19
非流动资产合计142,171,264.41153,861,833.35211,508,682.34190,410,963.85
资产总计2,381,919,508.52,415,027,980.822,414,261,322.992,386,313,068.04
流动负债合计296,518,295.05274,970,102.88278,664,145.19287,181,979.01
非流动负债合计40,160,903.6150,515,725.6153,254,498.9656,694,786.69
负债合计336,679,198.66325,485,828.49331,918,644.15343,876,765.7
归属于母公司股东权益合计2,045,240,309.842,089,542,152.332,083,093,735.682,042,663,654.13
股东权益合计2,045,240,309.842,089,542,152.332,082,342,678.842,042,436,302.34
负债和股东权益合计2,381,919,508.52,415,027,980.822,414,261,322.992,386,313,068.04
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计283,642,299.111,207,830,867.32841,311,762.23622,316,738.75
经营活动现金流出小计235,474,799.791,265,218,468.1964,184,885.08667,553,027.33
经营活动产生的现金流量净额48,167,499.32-57,387,600.78-122,873,122.85-45,236,288.58
投资活动现金流入小计1,361,505.0178,041,234.449,783,470.256,934,485.96
投资活动现金流出小计2,307,488.3106,906,986.4371,333,467.7156,871,961.71
投资活动产生的现金流量净额-945,983.29-28,865,751.99-61,549,997.46-49,937,475.75
筹资活动现金流入小计39,751,310.375,211,234.015,380,969.07304,346.33
筹资活动现金流出小计76,878,054.97143,517,035.93133,770,839.96118,726,156.19
筹资活动产生的现金流量净额-37,126,744.6-138,305,801.92-128,389,870.89-118,421,809.86
汇率变动对现金及现金等价物的影响-922,141.1-5,833,472.131,143,248.883,668,184.67
现金及现金等价物净增加额9,172,630.33-230,392,626.82-311,669,742.32-209,927,389.52
期末现金及现金等价物余额1,274,242,684.771,265,070,054.441,183,792,938.941,285,535,291.74
最新报告期:2024-04-26
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
开源证券余汝意1.492.002.312024-04-26
TOP↑